Indicators
Trend Forecast
Technical Analysis
| Risk Value | ₹3 |
|---|---|
| Risk % | 1.88% |
| Volatility | ₹2.39 |
| Last 50 Day High | ₹185.50 |
| Last 50 Day Min | ₹97.65 |
| Predicted Resistance | ₹172.36 |
| Predicted Floor | ₹157.69 |
| News | Sentiment |
|---|---|
| Buy BEL, SBI & Britannia equities for solid performance in next one year: Religare Broking's Ravi Singh | Neutral |
| Bliss GVS Pharma Q2 income rise 22% to Rs 41.45 cr | Neutral |
Regulatory Information
Regulation: First: Reg. 17 : Deals with the overall board composition and its functions for corporate governance. Second: : Third: :
Standard Operating Procedures (SOPs)
Ex Dividend Date Information
Ex Dividend Date: July 19, 2024
Earnings Date Information
Earnings Date: Jan. 21, 2025